NCT05795465 - A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 4, 2023

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions

Respiratory Distress Syndrome, Acute

Interventions

DRUG

GEn-1124

Intravenous infusion

DRUG

Placebo

Intravenous infusion

Trial Locations (11)

10029

RECRUITING

The Mount Sinai Hospital, New York

20010

WITHDRAWN

Medstar Washington Hospital Center, Washington D.C.

21061

RECRUITING

University of Maryland - Baltimore Washington Medical Center, Glen Burnie

21201

RECRUITING

University of Maryland Medical Center, Baltimore

39564

COMPLETED

Ocean Springs Hospital, Ocean Springs

44195

RECRUITING

Cleveland Clinic, Cleveland

63110

RECRUITING

Washington University School of Medicine, St Louis

66160

RECRUITING

University of Kansas Medical Center, Kansas City

77030

WITHDRAWN

Houston Methodist Hospital, Houston

84107

RECRUITING

Intermountain Medical Center, Murray

08103

RECRUITING

Cooper University Hospital, Camden